This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Aging Clinical and Experimental Research Open Access 16 April 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Chakradhar, S. Insurance companies are slow to cover next-generation sequencing. Nat Med 21, 204–205 (2015). https://doi.org/10.1038/nm0315-204
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0315-204
This article is cited by
-
Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
Aging Clinical and Experimental Research (2019)
-
The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients
Molecular Diagnosis & Therapy (2017)
-
Was it worth it? Patients’ perspectives on the perceived value of genomic-based individualized medicine
Journal of Community Genetics (2016)
